Concert Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Concert Wealth Management's NVS Position: Q2 2017 in Review
Concert Wealth Management sold out of Novartis (NVS) in Q2 2017, closing a stake of 7,286 shares — an estimated $475K sold.
Concert Wealth Management first reported a position in NVS in Q2 2013 and held it in 16 quarters. The position peaked at $975K in Q2 2015. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.
- Concert Wealth Management reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
- Concert Wealth Management sold 7,286 Novartis shares in Q2 2017, an estimated $475K.
- Concert Wealth Management first reported a position in Novartis in Q2 2013 and held it in 16 quarters.
- Concert Wealth Management's Novartis position peaked at $975K in Q2 2015.
- 920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.
Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.